Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.99% |
| 2 | Technology | 4.47% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Industrials | 3.78% |
| 5 | Healthcare | 3.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
PUT
Teva Pharmaceuticals
TEVA
$42.6B
| $35.9M | 0.02% |
2,329,300
+271,600
| +13% | +$5.57M |
|
777
CALL
Macy's
M
$6.27B
| $35.9M | 0.02% |
1,204,500
+26,800
| +2% | +$882K |
|
778
Federal Realty Investment Trust
FRT
$10.3B
| $35.9M | 0.02% |
303,804
+142,973
| +89% | +$18M |
|
779
CALL
Marathon Petroleum
MPC
$100B
| $35.7M | 0.02% |
605,500
+65,300
| +12% | +$4.46M |
|
|
SAFM
780
PUT
DELISTED
Sanderson Farms Inc
SAFM
| $35.7M | 0.02% |
359,800
+320,800
| +823% | +$32.8M |
|
781
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $35.7M | 0.02% |
342,600
+55,300
| +19% | +$5.6M |
|
|
CLR
782
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $35.6M | 0.02% |
884,870
+797,983
| +918% | +$40.8M |
|
783
Southern Company
SO
$107B
| $35.5M | 0.02% |
808,660
+369,305
| +84% | +$16.8M |
|
784
Papa John's
PZZA
$804M
| $35.4M | 0.02% |
890,268
-8,030
| -0.9% | -$405K |
|
785
CALL
RH
RH
$3.4B
| $35.4M | 0.02% |
295,400
-88,100
| -23% | -$10.6M |
|
786
CALL
Royal Caribbean
RCL
$82.9B
| $35.4M | 0.02% |
361,900
-26,000
| -7% | -$2.85M |
|
787
PUT
ProShares UltraPro QQQ
TQQQ
$38.7B
| $35.3M | 0.02% |
7,629,600
-1,667,200
| -18% | -$10.5M |
|
788
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $35.3M | 0.02% |
425,457
+316,646
| +291% | +$26.1M |
|
789
CALL
Take-Two Interactive
TTWO
$45.2B
| $35.2M | 0.02% |
342,200
+14,300
| +4% | +$1.65M |
|
790
CALL
Herbalife
HLF
$1.28B
| $34.9M | 0.02% |
592,500
+373,500
| +171% | +$20.6M |
|
791
CALL
Accenture
ACN
$109B
| $34.9M | 0.02% |
247,600
-78,000
| -24% | -$12.3M |
|
792
PUT
Vertex Pharmaceuticals
VRTX
$131B
| $34.7M | 0.02% |
209,600
+121,200
| +137% | +$21M |
|
793
DexCom
DXCM
$34.5B
| $34.7M | 0.02% |
1,158,680
-2,754,684
| -70% | -$87.4M |
|
|
BHVN
794
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $34.7M | 0.02% |
938,239
-42,508
| -4% | -$1.53M |
|
795
eBay
EBAY
$46.5B
| $34.7M | 0.02% |
1,235,370
+76,530
| +7% | +$2.25M |
|
796
PUT
American International
AIG
$39.8B
| $34.6M | 0.02% |
877,500
+326,000
| +59% | +$14.2M |
|
797
PUT
Automatic Data Processing
ADP
$110B
| $34.5M | 0.02% |
263,100
+20,500
| +8% | +$2.89M |
|
798
STMicroelectronics
STM
$48.1B
| $34.5M | 0.02% |
2,483,405
+1,938,416
| +356% | +$29M |
|
799
CALL
Domino's
DPZ
$11.6B
| $34.4M | 0.02% |
138,800
+29,900
| +27% | +$7.87M |
|
800
PUT
Tilray
TLRY
$640M
| $34.4M | 0.02% |
48,790
-49,120
| -50% | -$53.9M |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,237 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.